HUE050553T2 - Eljárás A módosulatú kalkobutrol kristályos alakjának elõállítására - Google Patents

Eljárás A módosulatú kalkobutrol kristályos alakjának elõállítására

Info

Publication number
HUE050553T2
HUE050553T2 HUE17768733A HUE17768733A HUE050553T2 HU E050553 T2 HUE050553 T2 HU E050553T2 HU E17768733 A HUE17768733 A HU E17768733A HU E17768733 A HUE17768733 A HU E17768733A HU E050553 T2 HUE050553 T2 HU E050553T2
Authority
HU
Hungary
Prior art keywords
calcobutrol
modification
producing
crystalline form
crystalline
Prior art date
Application number
HUE17768733A
Other languages
English (en)
Inventor
Johannes Platzek
Wilhelm Trentmann
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HUE050553T2 publication Critical patent/HUE050553T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/04Calcium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A61K49/108Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
HUE17768733A 2016-09-27 2017-09-11 Eljárás A módosulatú kalkobutrol kristályos alakjának elõállítására HUE050553T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16190812 2016-09-27

Publications (1)

Publication Number Publication Date
HUE050553T2 true HUE050553T2 (hu) 2020-12-28

Family

ID=57003447

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17768733A HUE050553T2 (hu) 2016-09-27 2017-09-11 Eljárás A módosulatú kalkobutrol kristályos alakjának elõállítására

Country Status (26)

Country Link
US (2) US10793532B2 (hu)
EP (1) EP3519394B1 (hu)
JP (2) JP7053590B2 (hu)
KR (1) KR102395523B1 (hu)
CN (1) CN109803958B (hu)
AR (1) AR109729A1 (hu)
AU (1) AU2017333698B2 (hu)
BR (1) BR112019006066A2 (hu)
CA (1) CA3038036C (hu)
CY (1) CY1123317T1 (hu)
DK (1) DK3519394T3 (hu)
ES (1) ES2809736T3 (hu)
HR (1) HRP20200922T1 (hu)
HU (1) HUE050553T2 (hu)
IL (1) IL265536B (hu)
LT (1) LT3519394T (hu)
MX (1) MX2019003540A (hu)
NZ (1) NZ751256A (hu)
PL (1) PL3519394T3 (hu)
PT (1) PT3519394T (hu)
RS (1) RS60392B1 (hu)
SG (1) SG11201901460UA (hu)
SI (1) SI3519394T1 (hu)
TW (1) TWI765913B (hu)
UY (1) UY37421A (hu)
WO (1) WO2018059914A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017333698B2 (en) * 2016-09-27 2020-12-24 Bayer Pharma Aktiengesellschaft Method for producing the crystalline form of modification a of calcobutrol
EP4083026A1 (en) * 2018-07-10 2022-11-02 Biophore India Pharmaceuticals Pvt. Ltd. Process for the preparation of 2,2',2''-(10-((2r,3s)-1,3,4-trihydroxy butan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl) triacetic acid and its complexes
EP3870569A4 (en) * 2018-10-24 2022-08-24 Biophore India Pharmaceuticals Pvt. Ltd. NEW PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELATING TRIACETIC ACID 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) AND ITS COMPLEXES WITH PARAMAGNETIC METALLIC IONS
CN111039885B (zh) * 2019-12-06 2021-03-05 广州康瑞泰药业有限公司 一种制备高纯度考布曲钙的方法
KR20210112910A (ko) * 2020-03-06 2021-09-15 주식회사 엔지켐생명과학 가도부트롤 주사제 제조를 위한 부형제인 칼코부트롤의 제조 방법
KR20210114742A (ko) * 2020-03-11 2021-09-24 주식회사 엔지켐생명과학 칼테리돌의 제조방법
CN114573522A (zh) * 2020-11-30 2022-06-03 江苏恒瑞医药股份有限公司 一种考布曲钙的新晶型及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491129A (en) 1975-06-04 1977-11-09 Guerbet Sa Iodo-benzene derivatives and an x-ray contrast medium containing them
US4284620A (en) 1979-03-23 1981-08-18 Mallinckrodt, Inc. N-(2-Hydroxyethyl)-2,4,6-triiodo-3,5-bis-(2-keto-L-gulonamido)benzamide and radiological compositions containing same
NO161560C (no) 1980-04-17 1989-09-06 Univ California Symmetriske trijodisoftaldiamid-derivater og roentgenkontrastmidler inneholdende disse.
DE3150916A1 (de) 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US5064633A (en) 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US5059412A (en) 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
MX174467B (es) 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3625417C2 (de) 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4009119A1 (de) 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH0899996A (ja) 1990-03-23 1996-04-16 Yamanouchi Europ Bv Il−6抑制組成物
DE4035760A1 (de) 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4237943C2 (de) 1992-11-06 1997-10-23 Schering Ag Verfahren zur Herstellung von Metallkomplexen der N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecan- und N-beta-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivate
US5410043A (en) 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
DE4218744C2 (de) 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
DE4318369C1 (de) 1993-05-28 1995-02-09 Schering Ag Verwendung von makrocyclischen Metallkomplexen als Temperatursonden
US5358704A (en) 1993-09-30 1994-10-25 Bristol-Myers Squibb Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
IT1275426B (it) 1995-05-16 1997-08-07 Bracco Spa Recupero del gadolinio e dei suoi agenti complessanti da soluzioni acquose contenenti i loro complessi
DE19724186C2 (de) 1997-06-02 2002-07-18 Schering Ag Verfahren zur Mono- und 1,7-Bis-N-ß-Hydroxyalkylierung von Cyclen und die entsprechenden N-ß-Hydroxyalkyl-1,4,7,10-tetraazacyclododecan-Li-Salz-Komplexe
US9016221B2 (en) 2004-02-17 2015-04-28 University Of Florida Research Foundation, Inc. Surface topographies for non-toxic bioadhesion control
DE102009053171B4 (de) 2009-11-04 2011-07-21 Bayer Schering Pharma Aktiengesellschaft, 13353 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol)
WO2012143355A1 (en) 2011-04-21 2012-10-26 Bayer Intellectual Property Gmbh Preparation of high-purity gadobutrol
US10463611B2 (en) * 2011-06-08 2019-11-05 Sti Pharma, Llc Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration
KR101693400B1 (ko) * 2014-09-17 2017-01-05 에스티팜 주식회사 칼코부트롤의 제조방법
CN105037288B (zh) * 2015-07-23 2017-11-03 上海现代制药海门有限公司 一种布醇的制备方法
CN106187930B (zh) * 2016-07-12 2018-10-19 嘉实(湖南)医药科技有限公司 高纯度考布曲钙的制备方法
AU2017333698B2 (en) 2016-09-27 2020-12-24 Bayer Pharma Aktiengesellschaft Method for producing the crystalline form of modification a of calcobutrol

Also Published As

Publication number Publication date
LT3519394T (lt) 2020-09-25
JP2019534869A (ja) 2019-12-05
IL265536A (en) 2019-05-30
AU2017333698A1 (en) 2019-03-07
NZ751256A (en) 2020-05-29
CN109803958A (zh) 2019-05-24
CA3038036A1 (en) 2018-04-05
UY37421A (es) 2018-01-31
EP3519394A1 (en) 2019-08-07
US20210009534A1 (en) 2021-01-14
RU2019111919A (ru) 2020-10-29
MX2019003540A (es) 2019-08-14
US11390592B2 (en) 2022-07-19
AU2017333698B2 (en) 2020-12-24
JP7444914B2 (ja) 2024-03-06
TW201815771A (zh) 2018-05-01
AR109729A1 (es) 2019-01-16
WO2018059914A1 (en) 2018-04-05
SG11201901460UA (en) 2019-03-28
US20190210979A1 (en) 2019-07-11
CA3038036C (en) 2024-01-23
CN109803958B (zh) 2023-10-31
PL3519394T3 (pl) 2020-11-30
JP7053590B2 (ja) 2022-04-12
CY1123317T1 (el) 2021-12-31
KR102395523B1 (ko) 2022-05-10
RS60392B1 (sr) 2020-07-31
US10793532B2 (en) 2020-10-06
ES2809736T3 (es) 2021-03-05
BR112019006066A2 (pt) 2019-06-18
IL265536B (en) 2022-07-01
HRP20200922T1 (hr) 2020-09-18
JP2022071132A (ja) 2022-05-13
EP3519394B1 (en) 2020-05-27
KR20190040064A (ko) 2019-04-16
DK3519394T3 (da) 2020-08-17
RU2019111919A3 (hu) 2020-12-28
SI3519394T1 (sl) 2020-08-31
TWI765913B (zh) 2022-06-01
PT3519394T (pt) 2020-08-03

Similar Documents

Publication Publication Date Title
IL289910A (en) A method for preparing allulose crystals
IL265536A (en) A method for the production of a crystalline form of the a modification of calcobuterol
SI3152176T1 (sl) Postopek za proizvodnjo cementne spojine
EP3524575C0 (en) METHOD FOR PRODUCING A LITHIUM COMPOUND
IL266044B (en) Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides
PL3378434T3 (pl) Sposób wytwarzania struktury dentystycznej
PT3206518T (pt) Um pezinho de meia assim como um método para produzir esse pezinho de meia
EP3666729C0 (en) PROCESS FOR THE PRODUCTION OF NANO-SULFUR
GB2572706B (en) A method for production of thymoquinone
IL264307B (en) Production method for a pyrazole-amide compound
EP3190087A4 (en) Method for producing crystalline silicotitanate
GB201811207D0 (en) Method for producing a decorative element
SG11201907182QA (en) Method for producing perfluoroalkadiene compounds
PL3511315T3 (pl) Sposób wytwarzania n-metylo-para-anizydyny
SG11202003954QA (en) Method for producing dihydroxyindoles
PL3489218T3 (pl) Sposób wytwarzania fenyloaminohydroksyantrachinonów
GB201601558D0 (en) Method for producing 3-hydroxypropionamide
HUE060775T2 (hu) Eljárás bisz-pirrolidin vegyületek elõállítására
GB201619463D0 (en) Method for producing allulose crystals
PT3609337T (pt) Método para o fabrico de uma composição intensificadora de aroma
PL3287014T3 (pl) Sposób wytwarzania kompozycji fitosteroli-fitostanoli
AU2016900956A0 (en) A method for the production of 2-substituted-3H-quinazolin-4-ones-II
AU2016900957A0 (en) A method for the production of 2-substituted-3H-quinazolin-4-ones-I
PL3219402T3 (pl) Sposób kształtowania wytłoczek do wytwarzania opakowań
ZA201604816B (en) Method for producing a component